Here are six things to know:
1. The company’s total revenue was $12.4 million, a 22 percent increase from the same quarter of 2016.
2. The company generated gross profits of $9.5 million in the third quarter.
3. OrthoPediatrics’ total operating expenses were $10.2 million, up 33.4 percent from the third quarter the year prior.
4. During the third quarter, the company’s net losses were $1.5 million, slightly greater than net losses of $0.8 million for the same quarter of 2016.
4. OrthoPediatrics launched the following products this quarter: PediFrag Pediatric Specific Clavicle Plate and Medial Patella Femoral Ligament Reconstruction System. The additions boost the company’s portfolio to 22 surgical systems.
6. Additionally, the company completed its initial public offering, earning $59.8 million in gross proceeds.
More articles on orthopedics:
Orthopedic surgeon to know: Dr. Nicolas Noiseux of University of Iowa Hospitals and Clinics
2 key factors in whether total joint replacement patients are discharged home or to extended care facilities
Bluetail Medical Group adds Dr. Chris Wolf to its ranks — 5 points
